← FDA Drug Approvals (Drugs@FDA)
AMBRISENTAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2019-03-28
Drug application
- FDA Application #
ANDA208252- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMBRISENTAN
- Generic name
- AMBRISENTAN
- Active ingredients
- AMBRISENTAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- WATSON LABS INC
- Manufacturer
- Actavis Pharma, Inc.
- First approval
- 2019-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown